Project Grant R01AG089237
Award Date
9/15/24
Completion Date
8/31/29
Dollars Obligated
$944K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Boston, MA 02215, USA
Similar Awards
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a $811,443 cluster randomized trial to evaluate the impact of a shared decision-making (SDM) training program for breast surgeons and a patient decision aid for women aged 70+ with early-stage, low-risk breast cancer. The goal is to reduce the use of low-value treatments, such as mastectomy, sentinel lymph node biopsy, and radiation therapy after breast-conserving surgery, without...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $624,000.00 to the University of Texas Health Science Center at Houston to explore a patient priorities care framework for improving breast cancer survivorship care for older women with multiple chronic conditions. The project aims to use this framework to identify patient priorities, incorporate them into treatment plans, and evaluate the feasibility and impact on treatment burden and quality...
This federal Project Grant award, provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program, supports research to investigate the effect of aging on CDC1 function and CD8 T cell immunity in tumors. The $176,040 award to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), will fund a study to understand how age-related declines in conventional type 1 dendritic cells (CDC1s) impact the effectiveness of CD8+ T cell...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $388,750 to The Washington University to conduct research on the role of senescent cancer-associated fibroblasts (senCAFs) in breast cancer progression. The key objectives are to: 1) Determine the organ-specific effects of senCAFs on metastatic breast cancer progression; 2) Examine how senCAFs impact extracellular matrix dynamics and tumor cell migration; and 3) Assess the impact of senCAFs on...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $460,000 Cooperative Agreement under CFDA 93.376 "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" to the Dana-Farber Cancer Institute, Inc. (DFCI) in Boston, MA. The 5-year award, effective September 30, 2024 through September 29, 2029, supports DFCI in providing comprehensive psychosocial and structural support services to improve quality of life for young breast...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $115,411.00 to evaluate dynamic changes in aging-related clinical decline among older survivors with early-stage non-small cell lung cancer. The award to Weill Medical College of Cornell University aims to identify multilevel determinants, including social determinants of health, associated with disparities in clinical decline trajectories. This longitudinal study of over 89,000 lung...
This $625,452 federal Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop and evaluate a life expectancy-informed clinical decision support intervention to guide colorectal cancer screening decisions in older adults. The project, led by the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, involves a collaboration with The Johns Hopkins University as a sub-awardee. The co-investigator from Johns Hopkins, Dr....
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $858,166 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct a randomized clinical trial of a targeted palliative care intervention for patients with metastatic breast cancer. The 5-year study aims to improve documentation of end-of-life care preferences, delivery of end-of-life care, and patient-reported outcomes for this...
This federal Project Grant award, totaling $4,991,950.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant is funding the "INVESTIGATION OF A MULTICANCER EARLY DETECTION TEST IN A HIGH-RISK MILITARY POPULATION" at the Dana-Farber Cancer Institute, Inc. (DFCI) in Boston, Massachusetts. The project aims to develop and evaluate a novel multicancer early detection test for use within a high-risk military...
This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $349,561 to The Regents of the University of California, San Francisco to conduct the "Promoting Gynecologic Cancer Patients with Frailty to Achieve Functional Recovery Cohort Study (PROOF Cohort Study)". The study aims to 1) objectively assess physical frailty in patients aged 50 and older with advanced ovarian or uterine cancer, and quantify associations with perioperative...